Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eli Lilly and : Lilly Declares Fourth-Quarter 2021 Dividend

10/18/2021 | 02:53pm EST

INDIANAPOLIS, Oct. 18, 2021 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2021 of $0.85 per share on outstanding common stock.

The dividend is payable on December 10, 2021 to shareholders of record at the close of business on November 15, 2021.

About Eli Lilly and Company  
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and www.lilly.com/news. F-LLY

Lilly Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) related to expected dividend payments and reflects Lilly's current beliefs and expectations. However, there are significant risks and uncertainties in pharmaceutical research and development, as well as in business development activities and capital allocation strategies related to the company's business and actual results may differ materially due to various factors.  For a further discussion of these and other risks and uncertainties that could cause actual results to differ from Lilly's expectations, please see Lilly's most recent Forms 10-K and 10-Q filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

Refer to:                     
Jordan Bishop; bishop_jordan@lilly.com; 317-473-5712 (Media)
Kevin Hern; hern_kevin_r@lilly.com; 317-277-1838 (Investors)   

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company)

 

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-declares-fourth-quarter-2021-dividend-301402561.html

SOURCE Eli Lilly and Company


ę PRNewswire 2021
All news about ELI LILLY AND COMPANY
11/24Truist Securities Adjusts Eli Lilly and Co.'s Price Target to $301 from $262, Keeps Buy..
MT
11/19BMO Capital Starts Eli Lilly at Outperform With $311 Price Target
MT
11/18Emgality Versus Nurtec ODT Head-To-Head Migraine Preventive Treatment Study Now Enrolli..
CI
11/18Fountain Therapeutics, Inc. announced that it has received $15 million in funding from ..
CI
11/17Lilly to Participate in Fourth Annual Evercore ISI HealthCONx Conference
PR
11/17PharmStars Announces Showcase Event for Inaugural Class
AQ
11/12REFILE-UPDATE 4-Biden will nominate industry-friendly Califf to lead U.S. FDA
RE
11/12Dicerna Pharmaceuticals to Receive Multimillion-Dollar Milestone Payments Under Collabo..
MT
11/12Lilly to supply 614,000 additional doses of abcellera, discovered bamlanivimab together..
AQ
11/12DICERNA PHARMA : Two Targets in Lilly Collaboration Meet Proof of Principle
DJ
More news
Analyst Recommendations on ELI LILLY AND COMPANY
More recommendations